INTRODUCTION
Caspases are a family of 12 cysteinyl aspartate-specific proteases traditionally classified as inflammatory or apoptotic (McIlwain et al., 2013) . Inflammatory caspases (caspase-1, -4, -5, and -12 in humans) mediate innate immune responses by cleaving precursors of proinflammatory cytokines such as IL1b and IL-18, thereby facilitating their secretion. The apoptotic caspases (caspase-3, -6, -7, -8, and -9) play a role in the regulation of programmed cell death.
Apoptosis comprises two convergent pathways: the intrinsic and extrinsic (Youle and Strasser, 2008) . The intrinsic pathway is controlled by the BCL-2 family of proteins, which is divided into three groups. The first contains prodeath BAK and BAX, the essential effectors of the pathway. Second are the prosurvival proteins (BCL-2, BCL-X L , BCL-W, MCL-1, and A1), whose function is to prevent activation of BAK and BAX by physically restraining them and by sequestering a third group of BCL-2 family members, the prodeath ''BH3-only '' proteins (e.g., BIM and BID) . In a healthy cell, prosurvival proteins keep BAK and BAX in check. Apoptotic signals trigger the BH3-only proteins to activate BAK/BAX. The latter induce mitochondrial outer-membrane permeabilization (MOMP), facilitating the efflux of factors, including cytochrome c, into the cytoplasm. Cytochrome c forms the apoptosome complex with APAF-1 and the inactive zymogen of the initiator caspase, caspase-9. This results in the activation of caspase-9, which then triggers the rest of the caspase cascade, culminating in activation of the effector caspases, caspase-3 and caspase-7.
The purpose of the caspase cascade remains an enigma. It mediates many of the hallmarks of apoptosis in vitro, such as DNA fragmentation and phosphatidylserine (PS) exposure, but is largely dispensable for the apoptotic death and clearance of cells in vivo. The hematopoietic system is a good example: Bak À/À Bax À/À mice exhibit a massive accumulation of mature blood cells, whereas mice with an Apaf-1
Casp3
À/À Casp7 À/À hematopoietic system show no significant perturbations in blood cell number (Lakhani et al., 2006; Lindsten et al., 2000; Marsden et al., 2002) . This dichotomy can be explained by the fact that the ''point of no return'' in apoptosis is BAK/BAX-mediated mitochondrial damage. Cells lacking BAK and BAX are resistant to a wide range of apoptotic stimuli; they do not exhibit cytochrome c release or caspase activation and are able to maintain clonogenicity (i.e., they can survive and generate viable progeny) (Lindsten et al., 2000; Wei et al., 2001) . In contrast, Apaf-1-or caspase-deficient cells exhibit only short-term resistance to apoptotic stimuli and do not retain clonogenic potential (Ekert et al., 2004; Marsden et al., 2002; van Delft et al., 2010) . Thus, although clearly capable of accelerating apoptosis, these and many other studies indicate that the apoptotic caspase cascade is not required for death to occur. This raises important questions as to why caspase-deficient mice exhibit phenotypic abnormalities. For example, loss of Apaf-1, caspase-9, or caspase-3 results in lethality associated with large ectopic cell masses in the forebrain (Kuida et al., 1996 (Kuida et al., , 1998 Yoshida et al., 1998) , and the hematopoietic stem cell (HSC) compartment is expanded in the absence of caspase-3 (Janzen et al., 2008) . Although this suggests an accumulation of cells otherwise destined to die, in both cases, the evidence points to a more complex mechanism. In the brain, controversy exists as to the extent of cell death in mice lacking the caspase cascade, and recent studies indicate that changes in morphogen gradients may underpin aberrant forebrain development (Honarpour et al., 2001; Nonomura et al., 2013; Oppenheim et al., 2001) .
HSCs present a similar conundrum. HSC survival is governed by BCL-2 family proteins. Deletion of prosurvival Mcl-1 leads to their death, whereas overexpression of Bcl-2 increases their number (Domen et al., 2000; Opferman et al., 2005) . This has led to a model whereby a proportion of HSCs undergo apoptosis during the normal course of hematopoiesis; hence, a reduction in apoptosis is proposed to lead to accumulation of HSCs in vivo (Orelio and Dzierzak, 2007) . The expansion of HSCs observed in caspase-3-deficient mice would accord with this notion. Intriguingly, however, the evidence suggests that, rather than accumulating through failure to die, Casp3 À/À HSCs proliferate due to abnormalities in cytokine signaling (Janzen et al., 2008) , suggesting potential non-cell death roles for the apoptotic caspase cascade. In fact, apoptotic caspases are increasingly implicated in other cellular processes such as differentiation (Yi and Yuan, 2009 ). In some cases, these roles are a byproduct of, or are associated with, apoptosis; in others, they appear to be ''nonapoptotic'' in nature. Here, we show that the caspase cascade functions during apoptosis to prevent dying cells from producing type I interferon (IFN). Bak-and Bax-mediated mitochondrial damage triggers the release of mitochondrial DNA (mtDNA), which is recognized by the cGAS/STING-mediated cytosolic DNA sensing pathway. In the absence of the apoptotic caspases, this leads to the induction of IFN-b transcription and IFN-b secretion by the dying cell. Loss of the caspase cascade leads to elevated IFN-b levels in vivo. This feeds back to, and has a profound impact on, the HSC compartment, which is highly sensitive to the effects of type I IFN. Thus the apoptotic caspase cascade regulates the immunological impact an apoptotic cell has on the host by preventing damage-associated molecular pattern (DAMP) signaling induced by mtDNA.
RESULTS

HSC Expansion and Dysfunction in the Absence of Caspase-9
To define the requirement for the intrinsic apoptosis pathway ( Figure 1A ) in HSC homeostasis, we generated mice lacking Bak and Bax or caspase-9. Because these animals die postnatally, we first profiled the HSC-containing lineage Figure 2H ).
HSC Expansion in Caspase-9-Deficient Mice Is Caused by Type I Interferons Type I IFNs have been shown to induce HSC proliferation, leading to functional exhaustion in vivo (Essers et al., 2009; Sato et al., 2009) . We therefore generated mice doubly deficient for caspase-9 and the type I IFN receptor (Ifnar1). Although loss of Ifnar1 did not rescue postnatal lethality of Casp9 Means were compared to WT using a one-way ANOVA with Bonferroni correction. Data represent the mean ± SEM. *p % 0.05, **p % 0.01, and ***p % 0.005.
with Ifnar1 (E) Top ten gene sets (ranked by p value) from GSEA of Bak
(F and G) Real-time qPCR analysis of type I ISGs in fetal liver (F) and bone marrow cells (G) (n = 3-4 E13.5 fetal livers and 3-4 bone marrow chimeras per genotype).
(H) IFN-b protein in serum of WT (n = 6), Casp9 À/À (n = 6), and Bak
Unless indicated, means were compared to WT using a one-way ANOVA with Bonferroni correction. Data represent the mean ± SEM. *p % 0.05, **p % 0.01, and ***p % 0.005.
contrast, when apoptosis was triggered in the presence of the pan-caspase inhibitor Q-VD-Oph, IFN-b was produced (Figure 4C) . To test whether this mechanism is conserved between mice and humans, peripheral blood mononuclear cells (PBMCs) were isolated from the blood of five healthy adult donors and treated with ABT-737. Caspase-3/7 activation and loss of cell viability was observed over 24 hr (Figures 4D and 4E) . Upon coincubation with ABT-737 and Q-VD-Oph, IFN-b secretion was observed in all five human PBMC samples ( Figure 4F ). These data demonstrated that, in both human and murine hematopoietic cells, caspase-inhibited apoptosis results in the production of IFN-b.
Apoptotic MEFs Produce Type I IFN When Caspases Are Inhibited
To better examine the role of the intrinsic apoptosis pathway, we utilized immortalized mouse embryonic fibroblasts (MEFs). WT MEFs are dependent on the prosurvival proteins Mcl-1 and Bcl-x L for survival ( Figure 5A ). MEFs lacking Mcl-1 undergo Bak-and Bax-mediated apoptosis in response to ABT-737 (van Delft et al., 2006) . We therefore treated multiple Mcl1 Figure 5D ). Upregulation of Ifnb1, the gene encoding IFN-b, was evident 4 hr posttreatment ( Figure 5E ). These data demonstrate that nonhematopoietic cells also produce IFN-b when undergoing caspase-inhibited apoptosis and implicate Bak and Bax as the initiators of the signal that triggers IFN-b production. Means were compared to WT using a one-way ANOVA with Bonferroni correction. Data represent the mean ± SEM. *p % 0.05, **p % 0.01, and ***p % 0.005.
production when either the apoptotic initiator (caspase-9) or effector (caspase-3/7) caspases are inactivated. We reasoned that eliminating Bak and Bax would remove the stimulus for IFN-b production in caspase-deficient mice. To test this, we generated Casp9
, and Bak À/À Bax À/À Casp9 À/À bone marrow chimeras.
16 weeks posttransplantation, LSKs were increased in recipients of Apaf1 Figure 5N ). Thus, deletion of Bak and Bax prevents IFNb production and HSC dysfunction in mice lacking a functional apoptotic caspase cascade. ) bystanders, type I IFN response genes were strongly induced in bystanders cocultured with apoptotic cells (Figure 6D ), indicating that cells undergoing caspase-inhibited apoptosis actively transcribe Ifnb1 and secrete bioactive IFN-b.
Apoptotic IFN Production Is Driven by Mitochondrial DNA Considering the mechanism by which Bax and Bax stimulate a cell to produce type I IFN, we reasoned that release of a mitochondrial factor into the cytoplasm could be the initiating event. In the context of microbial invasion, type I IFNs are induced by a range of pathogen-associated molecular patterns (PAMPs). Viral nucleic acids are an important, and potent, example. Their presence is detected by cytosolic receptors that activate signaling cascades leading to the upregulation of IFN transcription (Paludan and Bowie, 2013) . We hypothesized that Bak-and Bax-mediated damage to mitochondria may cause the release of mtDNA and that the latter would act as a DAMP capable of recognition by the dying cell's innate nucleic acid sensors. We therefore generated mtDNAdepleted cells (so-called ''r 0 '' cells) by culturing Mcl1
MEFs in ethidium bromide (King and Attardi, 1989) . qPCR analysis revealed a near-complete absence of mtDNA after three passages ( Figures 6E and S4 Unless otherwise indicated, means were compared to WT using a one-way ANOVA with Bonferroni correction. Data represent the mean ± SEM. *p % 0.05, **p % 0.01, and ***p % 0.005.
were downregulated and 61 genes (corresponding to 82 probes) were upregulated ( Figure 6F and Table S2 ). 18 probes corresponding to 9 mitochondrially encoded genes were present on the array. These were the most downregulated genes in r 0 cells (Camera p value = 0.0095). Gene set analysis using Camera detected no significant enrichment for any of the c2 Figures 6I and 6J ). In the presence of Q-VD-Oph, IFN-b production was observed in the parental, but not r 0 , cells ( Figure 6K ). These data indicate that mtDNA is the trigger for IFN production downstream of Bak-and Bax-mediated mitochondrial damage.
Bak/Bax-Mediated mtDNA Release Triggers cGAS/ STING-Dependent IFN Production Two major pathways that mediate type I IFN production in response to intracellular microbial DNA have been described (Paludan and Bowie, 2013) . The first is initiated by Toll-like receptor 9 (Tlr9) recognition of DNA localized to endosomes, which triggers Myd88 signaling. Deletion of Myd88 in Casp9 À/À chimeras failed to normalize serum IFN-b levels and did not prevent LSK expansion ( Figure S5 ), suggesting that mtDNA-induced IFN-b production does not require the Tlr-mediated endosomal recognition pathway. The second is the stimulator of interferon genes (STING) pathway (Barber, 2014) . It is triggered when DNA binds to cyclic GMP-AMP synthase (cGAS), thereby catalyzing production of cyclic GMP-AMP dinucleotide (cGAMP), which binds to and activates STING. Figure 7I ). These data demonstrate that caspase-inhibited apoptosis triggers cGAS/STING/Tbk1/Irf3-mediated IFN-b production. Recent evidence indicates that cGAS is activated via a direct interaction with cytosolic DNA (Civril et al., 2013; Sun et al., 2013) . To establish whether mtDNA interacts with cGAS during caspase-inhibited apoptosis, we immunoprecipitated cGAS from Mcl1 À/À MEFs treated with ABT-737 and Q-VD-Oph and utilized qPCR analysis to detect coprecipitated DNA. Although there was no mtDNA enrichment when cGAS was immunoprecipitated from untreated cells, a significant enrichment for mtDNA, but not genomic DNA, was observed in cells treated with ABT-737 and Q-VD-Oph ( Figure 7J ). Collectively, these data indicate that mtDNA is released, binds to, and activates cGAS during caspase-inhibited apoptosis.
DISCUSSION
Role of the Intrinsic Apoptosis Pathway in HSC Homeostasis
Deletion of Bak and Bax had no impact on the number of immunophenotypic HSCs in the fetal liver, suggesting that the intrinsic apoptosis pathway is dispensable for HSC homeostasis during development. Upon transplantation, recipients of Bak À/À Bak À/À FLCs exhibited a statistically significant 2-fold increase in bone marrow LSK number. This increase is similar to that reported for mice overexpressing Bcl-2 (Domen et al., 2000) and supports a role for the intrinsic pathway in regulating adult HSC homeostasis. However, a simpler explanation might be that HSCs lacking Bak and Bax are more resistant to the stresses of transplantation. Consistent with this, Bak
FLCs outcompeted WT counterparts in mixed transplants. Similar effects have been reported for HSCs lacking Bim (Labi et al., 2013) . Thus, the extent to which death via the intrinsic apoptosis pathway shapes the HSC pool at steady state remains to be determined. It may be that programmed cell death does not represent a significant fate for HSCs. Alternatively, other cell death modalities such as the extrinsic apoptosis pathway or necroptosis might contribute to HSC homeostasis.
Apoptotic versus Nonapoptotic Roles for Apoptotic Caspases
Apoptotic caspases have been ascribed a number of functions beyond the internal demolition of dying cells. Some of these (e.g., prostaglandin-induced tumor cell repopulation [Huang et al., 2011] and AMPA receptor internalization [Li et al., 2010b] ) appear to be a byproduct of apoptotic cell death. Others (e.g., iPS cell reprogramming [Li et al., 2010a] and microglia activation [Burguillos et al., 2011] ) are thought to represent ''nonapoptotic'' roles for caspases. Our genetic experiments, both in vitro and in vivo, demonstrate that, in suppressing IFN production, the apoptotic caspases play an apoptotic role, i.e., function downstream of Bak and Bax. Unless Bak and Bax are activated, mtDNA is not released, and caspases are not required to attenuate mtDNA-induced DAMP signaling. This has two important implications. First, blocking the apoptotic caspase cascade during apoptosis triggers the production of IFN-b, a potentially significant confounding experimental factor. This should be considered whenever the apoptotic caspase cascade is genetically or pharmacologically manipulated. Perturbations in type I IFN signaling may explain some of the published biological roles for caspases. Second, the fact that caspase-deficient mice present with a dramatic increase in LSKs, whereas Bak À/À Bax À/À animals do not, initially suggested that caspases play a ''nonapoptotic'' role in HSCs. However, the subsequent experiments with Bak À/À Bax À/À Casp9 À/À cells and bone marrow chimeras demonstrated that the phenotype is dependent on Bak/Bax activation. This highlights the importance of establishing whether apoptotic caspase activation in a given setting is the result of (legend continued on next page) upstream mitochondrial damage or an alternative signaling mechanism.
mtDNA Activates the STING-Dependent Cytosolic DNA Sensing Pathway Our data indicate that Bak/Bax-dependent mtDNA release triggers the cGAS/STING-dependent cytosolic DNA sensing pathway. mtDNA released during cell death has been previously reported to provide a second signal that cooperates with signal 1 (e.g., LPS) to activate the NLRP3 inflammasome and induce IL1b production (Shimada et al., 2012) . Whether mtDNA released via Bak/Bax also activates the inflammasome is unclear. However, other than IFN-b, mice with a caspase-9-deficient hematopoietic system did not exhibit elevated proinflammatory cytokine serum levels or any signs of systemic autoinflammatory disease when aged to 12 months ( Figure S6 ). This suggests that, at least in the context of steady-state hematopoietic cell turnover, Bak/ Bax-mediated mtDNA release does not result in unbridled inflammasome activity when the caspase cascade is inactivated.
Whether the elevations in IFN-b caused by loss of the caspase cascade lead to the development of autoimmune disease over the longer term and whether perturbations in caspase activity might contribute to human autoinflammatory/autoimmune disease remain to be established.
Mechanisms of Caspase-Mediated Suppression of Type I IFN
During apoptosis, caspases orchestrate a global program of cellular demolition, targeting $1,000 protein substrates (Crawford and Wells, 2011). They cause DNA damage, suppress transcription, shut down protein translation, and disable a host of other essential cellular processes. Unlike genomic damage, which is triggered by cleavage of iCAD, the inhibitor of caspase-activated DNase (CAD) (Enari et al., 1998) , and PS exposure, which is facilitated by cleavage of Xkr8 (Suzuki et al., 2013) , it seems likely that caspase-mediated suppression of IFN-b production (and DAMP signaling generally) is the result of multiple redundant processes. First, the fact that apoptotic CAD CRISPRÀ/À MEFs secrete detectable amounts of IFN-b suggests that CAD-mediated genomic damage contributes to the attenuation of gene expression ( Figure S7 ). Second, caspase-3/7 might cleave and inactivate a component or components of the type I IFN production pathway. There is evidence that IFN signaling intermediates, including Irf3, can be targeted by caspases (Crawford et al., 2013) . Third, caspase-3/7 could mediate the degradation of mtDNA, thereby preventing its interaction with cGAS. This might occur via CAD or perhaps lysosomal deoxyribonuclease (DNase) II, which can digest the genomic DNA of engulfed cells. Although the precise contribution these and other mechanisms make to suppressing IFN-b production in apoptotic cells remains to be established, it seems unlikely that any one of them is solely responsible. We suggest that caspase-mediated acceleration of cell death and suppression of DAMP signaling are inextricably linked. Both outcomes are achieved via global cellular demolition.
Potential Crosstalk between Apoptosis and Necroptosis
Necroptosis is a regulated form of necrotic cell death mediated by receptor-interacting protein kinase 3 (RIPK3) and the pseudokinase Mlkl (Linkermann and Green, 2014) . It is triggered by prodeath ligands like TNFa and requires the inhibition or loss of caspase-8. In vitro, necroptosis is typically induced by TNFa and a caspase inhibitor such as z-VAD.fmk or Q-VDOph. The latter are both broad-spectrum inhibitors that target caspase-8, caspase-9, and caspase-3/7 (Chauvier et al., 2007) . If necroptotic stimuli induce mitochondrial damage and mtDNA release, our results would predict that pan-caspase inhibition would result in IFN production by dying cells. Previous studies suggest that necroptosis triggered by TNFa, z-VAD.fmk, and cycloheximide causes Bak/Bax-dependent mitochondrial damage (Irrinki et al., 2011) and that Bak
MEFs are partially protected from necroptotic death induced by TNFa, Q-VD-Oph, and a Smac mimetic (TSQ) (Moujalled et al., 2013) . Given that, like TNFa, type I IFNs, in combination with caspase inhibition, can induce necroptosis (Dillon et al., 2014; Thapa et al., 2013) , our data suggest the potential for feed-forward effects driven by mtDNA-induced IFN production during caspase-inhibited necroptosis.
Pharmacological Inhibition of Apoptotic Caspases
Several caspase inhibitors have undergone clinical trials. They include the caspase-1 inhibitors VX-740 and VX-765 (Belnacasan) and the pan-caspase inhibitors IDN-6556 (Emricasan) and GS-9450 (O'Brien and Dixit, 2009 ). To date, none have received approval, although IDN-6556 is in ongoing trials for a number of indications, including alcoholic hepatitis, hepatic impairment, and islet transplantation. Evidence that VX-765 can block the pyroptotic death of HIV-infected CD4 T cells (Doitsh et al., 2014) has added to the hope that caspase inhibitors may yet find clinical application. That study highlighted their potential as a new class of antiviral drugs that target the host, not the virus. Our findings support this notion from an entirely different angle, suggesting that apoptotic caspase inhibition might be an effective means of amplifying endogenous IFN production. It will be interesting to see whether patients treated with a pancaspase inhibitor exhibit elevations in IFN-b levels.
Caspases Negatively Regulate DAMP Signaling
The traditional classification of caspases as inflammatory or apoptotic has broken down in the last decade, as it has become (J) Immunoprecipitation (IP) followed by PCR. Left, immunoblot of lysates taken from Mcl1 À/À MEFs transduced with an expression plasmid encoding FLAGcGAS. Right, data represent the fold change (FC) in enrichment of DNA fragments using anti-FLAG or IgG (negative control) to coprecipitate DNA in untreated MEFs or MEFs treated with ABT-737 (1 mM) and Q-VD-OPh (QVD) (30 mM) for the indicated time. DNA fragments were amplified by real-time qPCR using eight primer pairs for mtDNA and two primer pairs for gDNA. The relative locations of the mtDNA amplicons are shown (data are combined from two, with three replicates). Means were compared between treated and untreated samples. See also Figures S5, S6 , and S7. Unless otherwise stated, means were compared using a two-tailed t test. Data represent the mean ± SEM. *p % 0.05, **p % 0.01, and ***p % 0.005.
apparent that inflammatory caspases such as caspase-1 can kill and that apoptotic caspases can mediate non-death processes. Our findings demonstrate that caspase-9, -3, and -7 are essential negative regulators of mtDNA-induced DAMP signaling. Although apoptotic caspases have been previously reported to inactivate the DAMPs HMGB1 (Kazama et al., 2008) and IL-33 (Cayrol and Girard, 2009; Lü thi et al., 2009) , the absence of autoinflammatory disease in caspase-9-deficient bone marrow chimeras suggests that, at least in the context of the hematopoietic system, apoptotic caspases are dispensable for their regulation. Alternatively, IFN-b may mask their effects. A very cogent review of this subject recently proposed that mammalian caspases ''can be construed to act as either positive or negative regulators of inflammation'' (Martin et al., 2012) . Given that type I IFNs are pleiotropic in nature, possessing both inflammatory and anti-inflammatory properties (Prinz and Knobeloch, 2012) , our results indicate that the apoptotic caspases serve as both.
EXPERIMENTAL PROCEDURES
Experimental Animals All mice were backcrossed for at least ten generations on a C57BL/6 background. Apaf1 À/À (Yoshida et al., 1998) , Bak À/À (Lindsten et al., 2000) , Bax À/À (Lindsten et al., 2000) , Casp9 À/À (Kuida et al., 1998) , Casp3 À/À (Kuida et al., 1996) , Casp7 À/À (Lakhani et al., 2006) , Ifnar1 À/À (Hwang et al., 1995) , 
Cell Death Assays
Cell death was induced by exposure to ABT-737 (AbbVie), Dexamethasone (Sigma), WEHI-539 (MedChemExpress), or Etoposide (Hospira). Where indicated, cells were preincubated for 1 hr with MRT-67307 (Sigma) and for 15-30 min with ABT-737, followed by continuous exposure to Q-VD-Oph (SM Biochemicals) or zVAD.fmk (R&D Systems). Cell viability was quantified by CellTiterGlo (Promega) or flow cytometric analysis of cells excluding 5 mg/ml propidium iodide (PI) (Sigma) and, where indicated, cells also negative for AnnexinV-FITC (InvivoGen) binding using a FACSCailbur (BD) or LSRII (BD). Caspase activity was assayed by the addition of caspase3/ 7Glo (Promega) or by immunoblotting as described in the Extended Experimental Procedures.
Measurement of IFN-b IFN-b protein was measured using the VeriKine-HS Human or Mouse Interferon Beta ELISA (PBL Assay Science).
Generation of mtDNA-Depleted r 0 Cells
MEFs were cultured in Dulbecco's modified Eagle's medium (DMEM) (GIBCO) supplemented with 4 mM L-glutamine, 4.5 g/l glucose, 10% FCS, 100 mg/ml sodium pyruvate, and 50 mg/ml uridine as described (Hashiguchi and ZhangAkiyama, 2009 ). 100 ng/ml ethidium bromide was added to the medium for 6-0 days. qPCR evaluation of mtDNA content by qPCR, transfection with Poly(I:C)(HMW)/LyoVec (InvivoGen), and expression profiling are described in Extended Experimental Procedures. 
Immunoprecipitation/PCR
Statistics
Data and statistical methods are expressed as outlined in figure legends. Standard statistical methods were performed using Prism software (GraphPad). Bonferroni post hoc test was used to correct for multiple testing.
ACCESSION NUMBERS
The Gene Expression Omnibus accession numbers for the microarray data sets reported in this paper are GSE57934 and GSE59972. 
SUPPLEMENTAL INFORMATION
